GMP Tumor Necrosis Factor Alpha Market Insights, Global Outlook and Forecast 2022-2028
GMP Tumor Necrosis Factor Alpha Market Insights, Global Outlook and Forecast 2022-2028
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Tumor necrosis factor alpha (TNF-α) is a cytokine that plays a central role in inflammation, immune system development, apoptosis, and lipid metabolism. It is mainly produced by monocytes and macrophages as a response to infection, injury, or tumor burden. TNF-α can also be produced from a range of other cell types such as T cells, natural killer cells (NK cells) and neutrophils.
The latest research study released by Market IntelliX evaluates market size and forecasts of GMP Tumor Necrosis Factor Alpha in Global, including the following market information:
Global GMP Tumor Necrosis Factor Alpha Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global GMP Tumor Necrosis Factor Alpha market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
25μg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of GMP Tumor Necrosis Factor Alpha include Miltenyi Biotec, Bio-Techne, GE Healthcare, Lonza, CellGenix, ReproCELL, PeproTech, Sino Biological and Creative Bioarray, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the GMP Tumor Necrosis Factor Alpha companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global GMP Tumor Necrosis Factor Alpha Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global GMP Tumor Necrosis Factor Alpha Market Segment Percentages, by Type, 2021 (%)
25μg
50μg
Others
Global GMP Tumor Necrosis Factor Alpha Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global GMP Tumor Necrosis Factor Alpha Market Segment Percentages, by Application, 2021 (%)
Cell/Gene Therapy
Tissue-Engineered Products
Others
Global GMP Tumor Necrosis Factor Alpha Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global GMP Tumor Necrosis Factor Alpha Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies GMP Tumor Necrosis Factor Alpha revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies GMP Tumor Necrosis Factor Alpha revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Miltenyi Biotec
Bio-Techne
GE Healthcare
Lonza
CellGenix
ReproCELL
PeproTech
Sino Biological
Creative Bioarray
Akron Biotech
Almog
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 GMP Tumor Necrosis Factor Alpha Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global GMP Tumor Necrosis Factor Alpha Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global GMP Tumor Necrosis Factor Alpha Overall Market Size
2.1 Global GMP Tumor Necrosis Factor Alpha Market Size: 2021 VS 2028
2.2 Global GMP Tumor Necrosis Factor Alpha Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top GMP Tumor Necrosis Factor Alpha Players in Global Market
3.2 Top Global GMP Tumor Necrosis Factor Alpha Companies Ranked by Revenue
3.3 Global GMP Tumor Necrosis Factor Alpha Revenue by Companies
3.4 Top 3 and Top 5 GMP Tumor Necrosis Factor Alpha Companies in Global Market, by Revenue in 2021
3.5 Global Companies GMP Tumor Necrosis Factor Alpha Product Type
3.6 Tier 1, Tier 2 and Tier 3 GMP Tumor Necrosis Factor Alpha Players in Global Market
3.6.1 List of Global Tier 1 GMP Tumor Necrosis Factor Alpha Companies
3.6.2 List of Global Tier 2 and Tier 3 GMP Tumor Necrosis Factor Alpha Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global GMP Tumor Necrosis Factor Alpha Market Size Markets, 2021 & 2028
4.1.2 25μg
4.1.3 50μg
4.1.4 Others
4.2 By Type - Global GMP Tumor Necrosis Factor Alpha Revenue & Forecasts
4.2.1 By Type - Global GMP Tumor Necrosis Factor Alpha Revenue, 2017-2022
4.2.2 By Type - Global GMP Tumor Necrosis Factor Alpha Revenue, 2023-2028
4.2.3 By Type - Global GMP Tumor Necrosis Factor Alpha Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global GMP Tumor Necrosis Factor Alpha Market Size, 2021 & 2028
5.1.2 Cell/Gene Therapy
5.1.3 Tissue-Engineered Products
5.1.4 Others
5.2 By Application - Global GMP Tumor Necrosis Factor Alpha Revenue & Forecasts
5.2.1 By Application - Global GMP Tumor Necrosis Factor Alpha Revenue, 2017-2022
5.2.2 By Application - Global GMP Tumor Necrosis Factor Alpha Revenue, 2023-2028
5.2.3 By Application - Global GMP Tumor Necrosis Factor Alpha Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global GMP Tumor Necrosis Factor Alpha Market Size, 2021 & 2028
6.2 By Region - Global GMP Tumor Necrosis Factor Alpha Revenue & Forecasts
6.2.1 By Region - Global GMP Tumor Necrosis Factor Alpha Revenue, 2017-2022
6.2.2 By Region - Global GMP Tumor Necrosis Factor Alpha Revenue, 2023-2028
6.2.3 By Region - Global GMP Tumor Necrosis Factor Alpha Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America GMP Tumor Necrosis Factor Alpha Revenue, 2017-2028
6.3.2 US GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.3.3 Canada GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.3.4 Mexico GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe GMP Tumor Necrosis Factor Alpha Revenue, 2017-2028
6.4.2 Germany GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.4.3 France GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.4.4 U.K. GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.4.5 Italy GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.4.6 Russia GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.4.7 Nordic Countries GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.4.8 Benelux GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia GMP Tumor Necrosis Factor Alpha Revenue, 2017-2028
6.5.2 China GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.5.3 Japan GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.5.4 South Korea GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.5.5 Southeast Asia GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.5.6 India GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America GMP Tumor Necrosis Factor Alpha Revenue, 2017-2028
6.6.2 Brazil GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.6.3 Argentina GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa GMP Tumor Necrosis Factor Alpha Revenue, 2017-2028
6.7.2 Turkey GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.7.3 Israel GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.7.4 Saudi Arabia GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
6.7.5 UAE GMP Tumor Necrosis Factor Alpha Market Size, 2017-2028
7 Players Profiles
7.1 Miltenyi Biotec
7.1.1 Miltenyi Biotec Corporate Summary
7.1.2 Miltenyi Biotec Business Overview
7.1.3 Miltenyi Biotec GMP Tumor Necrosis Factor Alpha Major Product Offerings
7.1.4 Miltenyi Biotec GMP Tumor Necrosis Factor Alpha Revenue in Global Market (2017-2022)
7.1.5 Miltenyi Biotec Key News
7.2 Bio-Techne
7.2.1 Bio-Techne Corporate Summary
7.2.2 Bio-Techne Business Overview
7.2.3 Bio-Techne GMP Tumor Necrosis Factor Alpha Major Product Offerings
7.2.4 Bio-Techne GMP Tumor Necrosis Factor Alpha Revenue in Global Market (2017-2022)
7.2.5 Bio-Techne Key News
7.3 GE Healthcare
7.3.1 GE Healthcare Corporate Summary
7.3.2 GE Healthcare Business Overview
7.3.3 GE Healthcare GMP Tumor Necrosis Factor Alpha Major Product Offerings
7.3.4 GE Healthcare GMP Tumor Necrosis Factor Alpha Revenue in Global Market (2017-2022)
7.3.5 GE Healthcare Key News
7.4 Lonza
7.4.1 Lonza Corporate Summary
7.4.2 Lonza Business Overview
7.4.3 Lonza GMP Tumor Necrosis Factor Alpha Major Product Offerings
7.4.4 Lonza GMP Tumor Necrosis Factor Alpha Revenue in Global Market (2017-2022)
7.4.5 Lonza Key News
7.5 CellGenix
7.5.1 CellGenix Corporate Summary
7.5.2 CellGenix Business Overview
7.5.3 CellGenix GMP Tumor Necrosis Factor Alpha Major Product Offerings
7.5.4 CellGenix GMP Tumor Necrosis Factor Alpha Revenue in Global Market (2017-2022)
7.5.5 CellGenix Key News
7.6 ReproCELL
7.6.1 ReproCELL Corporate Summary
7.6.2 ReproCELL Business Overview
7.6.3 ReproCELL GMP Tumor Necrosis Factor Alpha Major Product Offerings
7.6.4 ReproCELL GMP Tumor Necrosis Factor Alpha Revenue in Global Market (2017-2022)
7.6.5 ReproCELL Key News
7.7 PeproTech
7.7.1 PeproTech Corporate Summary
7.7.2 PeproTech Business Overview
7.7.3 PeproTech GMP Tumor Necrosis Factor Alpha Major Product Offerings
7.7.4 PeproTech GMP Tumor Necrosis Factor Alpha Revenue in Global Market (2017-2022)
7.7.5 PeproTech Key News
7.8 Sino Biological
7.8.1 Sino Biological Corporate Summary
7.8.2 Sino Biological Business Overview
7.8.3 Sino Biological GMP Tumor Necrosis Factor Alpha Major Product Offerings
7.8.4 Sino Biological GMP Tumor Necrosis Factor Alpha Revenue in Global Market (2017-2022)
7.8.5 Sino Biological Key News
7.9 Creative Bioarray
7.9.1 Creative Bioarray Corporate Summary
7.9.2 Creative Bioarray Business Overview
7.9.3 Creative Bioarray GMP Tumor Necrosis Factor Alpha Major Product Offerings
7.9.4 Creative Bioarray GMP Tumor Necrosis Factor Alpha Revenue in Global Market (2017-2022)
7.9.5 Creative Bioarray Key News
7.10 Akron Biotech
7.10.1 Akron Biotech Corporate Summary
7.10.2 Akron Biotech Business Overview
7.10.3 Akron Biotech GMP Tumor Necrosis Factor Alpha Major Product Offerings
7.10.4 Akron Biotech GMP Tumor Necrosis Factor Alpha Revenue in Global Market (2017-2022)
7.10.5 Akron Biotech Key News
7.11 Almog
7.11.1 Almog Corporate Summary
7.11.2 Almog Business Overview
7.11.3 Almog GMP Tumor Necrosis Factor Alpha Major Product Offerings
7.11.4 Almog GMP Tumor Necrosis Factor Alpha Revenue in Global Market (2017-2022)
7.11.5 Almog Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
GMP Tumor Necrosis Factor Alpha Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|